tiprankstipranks
Edesa Biotech Inc (EDSA)
NASDAQ:EDSA
US Market

Edesa Biotech (EDSA) Financial Statements

Compare
277 Followers

Edesa Biotech Financial Overview

Edesa Biotech's market cap is currently $17.06M. The company's EPS TTM is $-1.88; its P/E ratio is ―; Edesa Biotech is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22Sep 21Sep 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 328.80K
Gross Profit$ 0.00$ -183.47K$ -118.19K$ -118.79K$ 311.20K
Operating Income$ -7.01M$ -9.22M$ -18.37M$ -23.68M$ -6.40M
EBITDA$ -6.13M$ -8.19M$ -17.43M$ -13.22M$ -6.35M
Net Income$ -6.17M-$ -17.55M$ -13.34M$ -6.36M
Balance Sheet
Cash & Short-Term Investments$ 1.04M$ 5.36M$ 7.09M$ 7.84M$ 7.21M
Total Assets$ 3.81M$ 8.89M$ 11.58M$ 14.58M$ 10.76M
Total Debt$ 19.87K$ 94.49K$ 18.98K$ 99.32K$ 164.19K
Net Debt$ -1.02M$ -5.27M$ -7.07M$ -7.74M$ -7.05M
Total Liabilities$ 1.83M$ 1.84M$ 2.18M$ 1.53M$ 4.13M
Stockholders' Equity$ 1.98M$ 7.05M$ 9.39M$ 13.06M$ 6.63M
Cash Flow
Free Cash Flow$ -4.89M$ -6.64M$ -12.28M$ -13.67M$ -5.02M
Operating Cash Flow$ -4.89M$ -6.64M$ -12.28M$ -13.66M$ -4.99M
Investing Cash Flow$ 0.00$ 0.00$ -5.66K$ -6.15K$ 19.07K
Financing Cash Flow$ 592.03K$ 4.83M$ 11.63M$ 14.17M$ 7.09M
Currency in USD

Edesa Biotech Earnings and Revenue History

Edesa Biotech Debt to Assets

Edesa Biotech Cash Flow

Edesa Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis